Our flagship product is the ECAM FastTest for the COVID-19 pandemic. The ECAM FastTest is based on advanced lateral flow membrane assay diagnostic technology.
ECAM FastTest is a new generation of rapid testing which will enable people to go into confined environments with others, knowing they were free of the virus that day.
Scientists report* that up to 80% of transmission of SARS-CoV-2 virus is by so-called ‘superspreaders’ with a higher viral load, who may actually be asymptomatic up to 50% of the time. Routine and regular testing for COVID-19 by ECAM FastTest can enable the detection of potential superspreaders so they can self isolate and prevent further transmission. Reducing exposure to transmission risk is a valuable public health outcome for all.
* How ‘Superspreading’ Events Drive Most COVID-19 Spread – Scientific American and The timing of COVID-19 transmission
Optional Healthcare Test Product for Winter 21/22: ECAM FastTest for FluA and FluB
Product performance validation by Public Health England (PHE) Porton Down